National Institutes of Health

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing November 2, 2028.